贛鋒鋰業(01772.HK)曾升7% 旗下與賽力斯固態純電SUV擬今年上市
贛鋒鋰業(01772.HK)(002460.SZ)旗下贛鋒鋰電公布,在固態動力領域獲新突破,搭載贛鋒鋰電三元固液混合鋰離子電池的純電動SUV賽力斯-SERES-5規劃於今年上市。此外,贛鋒鋰電與賽力斯(601127.SH)將圍繞固態電池裝車應用展開深度合作。
目前,重慶贛鋒20GWh新型鋰電池科技產業園項目正在建設中,規劃建成內地最大的固態電池生產基地,助力更多車企實現動力系統迭代。
贛鋒鋰業H股一度升7.3%高見73.4元,半日收報72.4元,升5.8%,成交392萬股,涉資2.8億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.